19 Jun, 2013
The Leela Palace, Bengaluru
Monday, August 13, 2012 - 12:16 IST
Sun Pharma to buy remaining 34% of Taro for $592M
BY TEAM VCC
Sun’s revised offer per share is 5x the original deal struck in 2007; even with 61% premium over previous offer last October, Taro is cheaper, compared to peers.
Sun Pharmaceutical Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has reached an agreement to buy out the minority shareholders of New York Stock Exchange-listed Taro Pharmaceutical Industries and thereby take it private in a deal that...
To continue reading this article, you must be a Premium subscriber...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.
JOBS
- Associate - Red Fort Capital Advisors Pvt Ltd
- The Private Equity Associate - Nereus Capital
RECENT COMMENTS
- 21 May 2013AnooponThe biggest problem in Indian PE fund GPs is Ethics. They want Day-One-Carry rather than long term carry. There should...
- 20 May 2013varadhaonExits are not happening because a lot of businesses that PE funds invested into were not worthy of investments in the...
- 17 May 2013Santosh VermaonMohanjit, You have the ability to say something that can be said in 100 words in 5,000 words. Congrats on a well...
- 15 May 2013AMULYA DEonLAFARGE IS A VERY GOOD COMPANY AND GOOD NEWS FOR NEW PROJECT.
UPCOMING EVENTSchinetwork